このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

ステロイド耐性対ステロイド敏感性腎症候群における尿NGALの使用:体系的なレビューとメタ解析

  • 0Faculty of Medicine, University of Khartoum, Alqasr Avenue, P.O. Box 102, Khartoum, Sudan.

|

|

まとめ

この要約は機械生成です。

尿中の中性粒子のゼラチナーゼ関連リポカリン (NGAL) 濃度は,腎臓症候群の患者において有意に高い. ステロイド耐性腎症候群 (SRNS) とステロイド敏感性腎症候群 (SSNS) のNGAL濃度が高いことがNGALを示唆する.

科学分野

  • 腎臓科
  • バイオマーカー
  • グロメルール疾患

背景

  • 腎臓症候群は,変異性のあるコルチコステロイド反応による一般的な腎臓疾患である.
  • ステロイド感受性 (SSNS) とステロイド耐性 (SRNS) の早期の区別は,SRNSの予後が悪いため極めて重要です.
  • ニュートロフィルゼラチナーゼ関連リポカリン (NGAL) は管状損傷と潜在的な腎臓損傷を示すバイオマーカーです.

研究 の 目的

  • 尿中のNGAL濃度に関するSSNSとSRNSの研究を体系的にレビューし,メタ分析する.
  • 尿中のNGALがSSNSとSRNSを区別するための非侵襲的なバイオマーカーとしての可能性を評価する.

主な方法

  • PRISMAのガイドラインに沿った体系的なレビューとメタ分析.
  • 主要な科学データベースで 徹底した文献検索
  • 標準化された平均差 (SMD) の統計分析のためのランダム効果モデル.

主要な成果

  • 16件の研究がメタアナリシスに含まれていた.
  • 尿中のNGAL濃度は,SSNSとSRNSの両方において,健康な対照群と比較して有意に上昇した.
  • 尿中のNGAL濃度は,SRNS患者よりSSNS患者より著しく高かった (SMD=1,889).
  • ROCの分析では,尿中のNGALがSRNSとSSNSを区別する能力が中等から高いことが示された.

結論

  • 尿中のNGALは,非侵襲的なバイオマーカーとして有意な可能性を示しています.
  • NGALはSRNSとSSNSの区別を助け,その臨床的有用性を支持する.
  • このバイオマーカーは早期診断,リスクの分層化,患者管理に役立ちます.

関連する概念動画

Nephrotic Syndrome II : Assessment and Medical Management 01:26

21

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...

Nephrotic Syndrome I : Introduction 01:24

27

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

Nephrotic Syndrome III : Nursing Management 01:24

44

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

Acute Pyelonephritis II: Diagnostic Studies and Management 01:28

40

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Nursing Assessment of the Genitourinary System I: Health History 01:21

75

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...

Urinary Tract Calculi V: Nursing Management 01:28

28

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...